Last updated: March 15, 2022
Sponsor: Hospital St. Joseph, Marseille, France
Overall Status: Active - Recruiting
Phase
4
Condition
Connective Tissue Diseases
Treatment
N/AClinical Study ID
NCT04890431
OXYSED
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Aged ≥ 18 years;
- Diagnosed with EDS/HT defined by the New York critieria;
- With intense fatigue defined by an FSS ≥ 4;
- Having given free and informed written consent;
- Speaking french language;
- Being affiliated with or benefiting from a social security scheme.
Exclusion
Exclusion Criteria:
- with progressive parenchymal pulmonary pathology (pulmonary fibrosis, post-smokingemphysema);
- having an ongoing pregnancy or breastfeeding;
- who have already received oxygen therapy for the EDS / HT indication in the last 6months;
- having a pathology that causes fatigue, which is not compensated or treated;non-exhaustive list anemia, sleep apnea syndrome, psychiatric pathologies includingsevere depression, organ failure (cardiac, renal, respiratory, hepatic),endocrinopathies (hypo or hyperthyroidism, diabetes), nutritional deficiencies;
- Subject to a measure for the protection of justice.
Study Design
Total Participants: 82
Study Start date:
March 10, 2022
Estimated Completion Date:
January 31, 2024
Connect with a study center
Hopital Raymond Poincaré
Garches,
FranceActive - Recruiting
Clinique de la Mitterie
Lille,
FranceActive - Recruiting
Hopital Saint Joseph
Marseille,
FranceActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.